Helen M Colhoun

机构：Edinburgh Cancer Research

发表论文 5 篇 · 总被引 389 次 · h-index 3

代表论文

• Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial (2019 · The Lancet Diabetes & Endocrinology · 被引 330)
• Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials (2026 · The Lancet · 被引 29)
• Finerenone in Type 1 Diabetes and Chronic Kidney Disease (2026 · New England Journal of Medicine · 被引 27)
• Efficacy of COVID-19 vaccination in individuals designated as clinically extremely vulnerable in Scotland (2021 · F1000Research · 被引 3)
• Genome-wide aggregated <i>trans</i>-effects analysis for circulating proteins indicates a key role of immune checkpoints in type 1 diabetes (2025)